Changchun Genescience Pharmaceutical Co., Ltd.

This trial is testing whether daily injections of recombinant human growth hormone can improve growth in children with achondroplasia, a genetic condition that causes short stature. The study will include children aged 2 to 10 who have not previously been treated with growth horm…

This study tested a new drug called gentuximab combined with the chemotherapy drug paclitaxel in 76 people with advanced stomach or gastroesophageal junction cancer that had worsened after initial treatment. The goal was to find a safe and effective dose and see if the combinatio…

This early-phase trial tested a single injection of GenSci120 in 58 healthy adults to see if it is safe and how the body processes it. The drug aims to control the immune system, which could one day help people with autoimmune diseases. Because this is a Phase 1 study, it only lo…

This study tested a new tablet, GS1-144, to see if it can reduce moderate to severe hot flashes in postmenopausal women. 129 women took either the drug or a placebo for 12 weeks. The goal was to measure changes in hot flash frequency and severity, as well as quality of life.